JunB is essential for mammalian placentation

被引:212
作者
Schorpp-Kistner, M
Wang, ZQ
Angel, P
Wagner, EF
机构
[1] Deutsch Krebsforschungszentrum, Abt Signaltransdukt & Wachstumskontrolle, D-69120 Heidelberg, Germany
[2] Res Inst Mol Pathol, IMP, A-1030 Vienna, Austria
关键词
AP-1 transcription factor; embryonic lethality; gene targeting; junB; placental development;
D O I
10.1093/emboj/18.4.934
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Lack of JunB, an immediate early gene product and member of the AP-1 transcription factor family causes embryonic lethality between E8.5 and E10.0. Although mutant embryos are severely retarded in growth and development, cellular proliferation is apparently not impaired. Retardation and embryonic death are caused by the inability of JunB-deficient embryos to establish proper vascular interactions with the maternal circulation due to multiple defects in extra-embryonic tissues, The onset of the phenotypic defects correlates well with high expression of junB in wild-type extra-embryonic tissues. In trophoblasts, the lack of JunB causes a deregulation of proliferin, matrix metalloproteinase-9 (MMP-9) and urokinase plasminogen activator (uPA) gene expression, resulting in a defective neovascularization of the decidua, As a result of downregulation of the VEGF-receptor 1 (flt-1), blood vessels in the yolk sac mesoderm appeared dilated, Mutant embryos which escape these initial defects finally die from a nonvascularized placental labyrinth Injection of junB(-/-) embryonic stem (ES) cells into tetraploid wild-type blastocysts resulted in a partial rescue, in which the ES cell-derived fetuses were no longer growth retarded and displayed a normal placental labyrinth, Therefore, JunB appears to be involved in multiple signaling pathways regulating genes involved in the establishment of a proper fete-maternal circulatory system.
引用
收藏
页码:934 / 948
页数:15
相关论文
共 75 条
  • [51] 6::AID-DVG2&gt
  • [52] 3.0.CO
  • [53] 2-B
  • [54] M-TWIST EXPRESSION INHIBITS MOUSE EMBRYONIC STEM CELL-DERIVED MYOGENIC DIFFERENTIATION IN-VITRO
    ROHWEDEL, J
    HORAK, V
    HEBROK, M
    FUCHTBAUER, EM
    WOBUS, AM
    [J]. EXPERIMENTAL CELL RESEARCH, 1995, 220 (01) : 92 - 100
  • [55] A GENE ACTIVATED BY GROWTH-FACTORS IS RELATED TO THE ONCOGENE V-JUN
    RYDER, K
    LAU, LF
    NATHANS, D
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (05) : 1487 - 1491
  • [56] RYSECK RP, 1991, ONCOGENE, V6, P533
  • [57] DISTINCT ROLES OF THE RECEPTOR TYROSINE KINASES TIE-1 AND TIE-2 IN BLOOD-VESSEL FORMATION
    SATO, TN
    TOZAWA, Y
    DEUTSCH, U
    WOLBURGBUCHHOLZ, K
    FUJIWARA, Y
    GENDRONMAGUIRE, M
    GRIDLEY, T
    WOLBURG, H
    RISAU, W
    QIN, Y
    [J]. NATURE, 1995, 376 (6535) : 70 - 74
  • [58] THE CELL PROLIFERATION-ASSOCIATED ANTIGEN OF ANTIBODY KI-67 - A VERY LARGE, UBIQUITOUS NUCLEAR-PROTEIN WITH NUMEROUS REPEATED ELEMENTS, REPRESENTING A NEW KIND OF CELL CYCLE-MAINTAINING PROTEINS
    SCHLUTER, C
    DUCHROW, M
    WOHLENBERG, C
    BECKER, MHG
    KEY, G
    FLAD, HD
    GERDES, J
    [J]. JOURNAL OF CELL BIOLOGY, 1993, 123 (03) : 513 - 522
  • [59] HEMATOPOIETIC DEVELOPMENT OF EMBRYONIC STEM-CELLS INVITRO - CYTOKINE AND RECEPTOR GENE-EXPRESSION
    SCHMITT, RM
    BRUYNS, E
    SNODGRASS, HR
    [J]. GENES & DEVELOPMENT, 1991, 5 (05) : 728 - 740
  • [60] SCHNURCH H, 1993, DEVELOPMENT, V119, P957